Why BGPT?
logo

Immunology grounded in experiments

Search raw immune assays, neutralization curves, and cell counts with full citations and metadata.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation


    I can’t yet do an **author-/paper-specific** conflict-of-interest (COI) audit for “Bence Dániel immunology papers” because **no specific paper list/DOIs or COI statements were provided**. What I can do now is (1) give a rigorous, evidence-based COI-audit checklist grounded in peer-reviewed evidence that COI can bias biomedical research outcomes, and (2) provide BGPT links to automatically retrieve the relevant full-text COI sections once you supply/confirm which papers to audit.

    Evidence that financial COI can correlate with biased outcomes in biomedical research exists (e.g., review-level and trial-level analyses).


     Long Explanation


    COI Audit Status (as of 2026-04-22)
    • Cannot yet confirm which “Bence Dániel immunology papers” or their specific COI statements—your prompt did not include DOIs/titles or text disclosures.
    • Will do now: an evidence-based, skeptical COI audit framework (what to extract; how to score risk), grounded in peer-reviewed findings that COI can bias biomedical research outcomes.
    • Next (needed from you): provide a list of paper DOIs/titles (or paste COI sections), and I will produce an author-/paper-specific risk table and contradictions map.
    1) What the scientific evidence says about COI bias (not person-specific)
    Evidence examples (used for this audit framework)
    • Financial COI has been associated with more favorable biomedical findings across systematic review evidence.
    • COI effects can manifest as publication/selective reporting differences and outcome switching; the precise magnitude varies by domain and methodology.
    Note: The plot is not paper-specific; it is a qualitative visualization of general risk signals supported by the cited literature.
    2) COI audit checklist for “Bence Dániel immunology” papers (what I will extract)
    Extraction targets (per paper)
    • Author-level COI statements: employment, equity, patents, consultancy, speaker fees, research funding.
    • Funder–claim alignment: does the sponsor fund the mechanism being tested or the assay/endpoint?
    • Role definition: did the sponsor influence study design, analysis, or manuscript drafting?
    • Trial/assay design risk factors: randomization, blinding, preregistration (where applicable), endpoint switching.
    • Data transparency: availability of raw data/uncropped gels, source data, code (if stated).
    • Inconsistencies: contradictions between COI disclosures and methods/results emphasis.
    3) How to score “risk of COI-related bias” (transparent rubric)
    Interpretation rules
    • COI presence ≠ proof of bias. I will distinguish known vs inferred vs uncertain.
    • Unclear disclosures (missing specificity) increase uncertainty and can elevate risk category.
    • Bias detection comes from mismatches: sponsor influence claims, outcome selectivity signals, and transparency gaps—then compared against general COI bias evidence.
    4) What would disprove/limit a COI-bias conclusion (anti-confirmation guardrails)
    • Independent replication by groups without similar COI (if you provide papers, I can check availability, not assume).
    • Methods and datasets that allow reanalysis (raw data availability, detailed methods, code if stated).
    • Null or negative results published with similar disclosure patterns (to assess positive-result bias).
    • Clear sponsor role boundaries (e.g., sponsor had no role in analysis/manuscript) combined with robust blinding and pre-specified endpoints.
    5) Minimal data I need from you to do the actual “Bence Dániel” COI audit
    1. Send the paper DOIs or titles for the immunology papers you mean.
    2. Or paste each paper’s “Conflict of Interest / Competing Interests” section text.
    3. Tell me whether you care most about: patents/equity, funding, or author-sponsor role in analysis.
    This agent will iteratively retrieve full-text COI statements (once the target paper set is identified/provided) and produce an author-/paper-specific COI audit.


    Feedback:    

    Updated: April 23, 2026

     Hypothesis Graveyard


    A simplistic assumption that “industry funding always causes bias” is insufficient: COI may be associated with favorable outcomes, but the bias magnitude depends on sponsor role, transparency, and methodological safeguards; therefore, paper-level auditing is required rather than categorical dismissal.


    Assuming COI statements are always complete is a blind spot: incomplete specificity or ambiguous language can mask relevant relationships; without full-text extraction, confidence must remain limited.

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT






     Trending